The D3 receptor and improvement in positive symptoms of schizophrenia

被引：0

作者：

Staddon, S ^{[1
]}

Arranz, MJ ^{[1
]}

Mancama, D ^{[1
]}

Beperet, M ^{[1
]}

Munro, J ^{[1
]}

Osborne, S ^{[1
]}

Collier, D ^{[1
]}

Mata, I ^{[1
]}

Kerwin, R ^{[1
]}

机构：

[1] Inst Psychiat, London SE5 8AF, England

来源：

SCHIZOPHRENIA RESEARCH | 2002年 / 53卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

页码：152 / 152

页数：1

共 50 条

[11] HOMOZYGOSITY AT THE DOPAMINE D3 RECEPTOR LOCUS IS NOT ASSOCIATED WITH SCHIZOPHRENIA [J].

LAURENT, C ;

SAVOYE, C ;

SAMOLYK, D ;

MELONI, R ;

MALLET, J ;

CAMPION, D ;

MARTINEZ, M ;

DAMATO, T ;

BASTARD, C ;

DOLLFUS, S .

JOURNAL OF MEDICAL GENETICS, 1994, 31 (03) :260-260

[12] RELATIONSHIP BETWEEN HOMOZYGOSITY AT THE DOPAMINE D3 RECEPTOR GENE AND SCHIZOPHRENIA [J].

MANT, R ;

WILLIAMS, J ;

ASHERSON, P ;

PARFITT, E ;

MCGUFFIN, P ;

OWEN, MJ .

AMERICAN JOURNAL OF MEDICAL GENETICS, 1994, 54 (01) :21-26

[13] Dopamine D3 receptor and schizophrenia: A widened scope for the immune hypothesis [J].

Vogel, Matthias ;

Busse, Stefan ;

Freyberger, Harald J. ;

Grabe, Hans Joergen .

MEDICAL HYPOTHESES, 2006, 67 (02) :354-358

[14] Dopamine and glutamate dysfunctions in schizophrenia:: Role of the dopamine D3 receptor [J].

Leriche, L ;

Diaz, J ;

Sokoloff, P .

NEUROTOXICITY RESEARCH, 2004, 6 (01) :63-71

[15] No linkage or association between schizophrenia and the dopamine D3 receptor polymorphism [J].

Hawi, Z ;

Straub, RE ;

ONeill, A ;

Kendler, KS ;

Walsh, D ;

Gill, M .

AMERICAN JOURNAL OF MEDICAL GENETICS, 1997, 74 (06) :625-625

[16] Dopamine D3 receptor gene variants and substance abuse in schizophrenia [J].

Krebs, MO ;

Sautel, F ;

Bourdel, MC ;

Sokoloff, P ;

Schwartz, JC ;

Olie, JP ;

Loo, H ;

Poirier, MF .

MOLECULAR PSYCHIATRY, 1998, 3 (04) :337-341

[17] Dopamine D3 receptor gene variants and substance abuse in schizophrenia [J].

M-O Krebs ;

F Sautel ;

M-C Bourdel ;

P Sokoloff ;

J-C Schwartz ;

J-P Olié ;

H Lôo ;

M-F Poirier .

Molecular Psychiatry, 1998, 3 :337-341

[18] Dopamine and glutamate dysfunctions in schizophrenia: Role of the dopamine D3 receptor [J].

Ludovic Leriche ;

Jorge Diaz ;

Pierre Sokoloff .

Neurotoxicity Research, 2004, 6 :63-71

[19] Cariprazine, a selective dopamine D3 receptor partial agonist with unique features to treat schizophrenia negative and cognitive symptoms [J].

Laszlovszky, I. ;

Barabassy, A. ;

Kiss, B. ;

Szatmari, B. ;

Adham, N. ;

Earley, W. ;

Nemeth, G. .

EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 :S398-S399

[20] Linkage, association and mutational analysis of the dopamine D3 receptor gene in schizophrenia [J].

Asherson, P ;

Mant, R ;

Holmans, P ;

Williams, J ;

Cardno, A ;

Murphy, K ;

Jones, L ;

Collier, D ;

McGuffin, P ;

Owen, MJ .

MOLECULAR PSYCHIATRY, 1996, 1 (02) :125-132

← 1 2 3 4 5 →